Combining metagenomics and network analyses identifies microbial interactions and their mechanism

Understanding the formation and functioning of microbial communities is important for all microbiome applications. We developed an approach to identify vitamin exchange in microbial communities and validated this approach by isolating and characterizing a predicted vitamin producer in the lab.
Published in Microbiology
Combining metagenomics and network analyses identifies microbial interactions and their mechanism
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Bacteria seldom live alone, instead, they live within microbial communities where they exchange goods such as amino acids, nucleotides and vitamins. Exchanging these compounds reduces the number of compounds an organism needs to synthesize, and frees up time and energy for other important processes. Exchanging these metabolites can therefore be highly advantageous and is common across microbial communities. We can be sure that vitamins are commonly exchanged among bacteria because many vitamins are essential for microbial growth yet a large proportion of bacteria don’t encode the genes necessary for their production (Figure 1).

Figure 1. The proportion of Proteobacterial genera genomes in GTDB that have the capacity to synthesize thiamine (vitamin B1), a near essential vitamin required for central metabolism and other cellular processes.



We supposed that organisms unable to produce particular vitamins may rely on specific vitamin-producing bacteria and we would, therefore, be able to observe this dependence across many samples by constructing correlation-based networks. To do this, we used metagenomic data associated with a range of bioreactors operated under 92 similar but varied conditions. We used metagenomic data to assess each microorganism’s genetic potential and determined whether each organism was able or unable to produce particular vitamins. We then overlaid this information onto the correlation network (Figure 2). 

Figure 2. Correlation network based on 92 metagenomic bioreactor communities. The nodes represent organisms within the communities and the edges represent a correlation between two organisms. Coloring shows which organisms encode and which lack the capacity to produce thiamine. Nodes with a bold border were found to be important for network connectivity.

Considering the number of connections between vitamin-producing and auxotrophic bacteria (unable to produce a vitamin), we could estimate how important each organism within the network may be for the production of a given vitamin (Figure 3). Using this approach we identified a number of organisms that we predict to be important for supplying several B vitamins including thiamine, riboflavin, pantothenate and biotin to dependent organisms in their communities. 

Figure 3. The estimated importance of each thiamine-producing bacteria for the provisioning of this vitamin to other organisms. This considered the number of both vitamin auxotrophs and vitamin producers in each organism’s (node) local network neighborhood. 

We then isolated many organisms from bioreactors performing thiocyanate degradation, including the predicted thiamine-producer, Variovorax. We first wanted to confirm that co-culturing Variovotrax with a thiamine auxotroph would boost the growth of the auxotroph. During our isolation campaign, we isolated a yeast, Cryptococcus, which was only able to grow in minimal media if thiamine was supplemented to the medium, making it an ideal biosensor to detect thiamine. Co-culturing these organisms together enabled Cryptococcus to grow to ~100-fold greater cell number than in pure culture, indicating that Variovorax was likely producing this vitamin. To confirm this, we then assayed the media during the growth of Variovorax and found it had produced ~100 mg/L of thiamine (Figure 4), far more than typical thiamine-producing bacteria (0.5-10 mg/L).

Figure 4. Variovorax produces up to ~100 mg/L of thiamine (vitamin B1), far more than other naturally occurring thiamine-producing bacteria.

Interestingly, we found Variovorax was unable to produce its own pantothenate (vitamin B5), and supplying this vitamin to Variovorax shortens its lag phase and increases the amount of thiamine it produces. This led us to hypothesize that this organism's almost extreme thiamine-producing trait has evolved to encourage the growth of other bacteria that provide Variovorax with other compounds including pantothenate. The study demonstrates the value of combining metagenomics and network analyses to detect microbial interactions and, importantly, determine their mechanisms. This enables us to gain a better understanding of the metabolic functioning of particular organisms and microbial communities as a whole.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Microbiology
Life Sciences > Biological Sciences > Microbiology

Related Collections

With collections, you can get published faster and increase your visibility.

Advances in catalytic hydrogen evolution

This collection encourages submissions related to hydrogen evolution catalysis, particularly where hydrogen gas is the primary product. This is a cross-journal partnership between the Energy Materials team at Nature Communications with Communications Chemistry, Communications Engineering, Communications Materials, and Scientific Reports. We seek studies covering a range of perspectives including materials design & development, catalytic performance, or underlying mechanistic understanding. Other works focused on potential applications and large-scale demonstration of hydrogen evolution are also welcome.

Publishing Model: Open Access

Deadline: Sep 18, 2024

Cancer epigenetics

With this cross-journal Collection, the editors at Nature Communications, Communications Biology, Communications Medicine, and Scientific Reports invite submissions covering the breadth of research carried out in the field of cancer epigenetics. We will highlight studies aiming at the improvement of our understanding of the epigenetic mechanisms underlying cancer initiation, progression, response to therapy, metastasis and tumour plasticity as well as findings that have the potential to be translated into the clinic.

Publishing Model: Open Access

Deadline: Oct 31, 2024